ROBERT RITCH
Medical Practice in New York, NY
License number
New Jersey 25MA03092900
Issued Date
Nov 14, 1975
Expiration Date
Jun 30, 2011
Category
Medical Examiners
Type
Medical Doctor
Address
Address
New York, NY
Personal information
See more information about ROBERT RITCH at radaris.comName
Address
Phone
6600 Dysinger Rd APT 8, Lockport, NY 14094
455 E 57Th St APT 14D, New York, NY 10022
21 Edgewood Rd, Hartsdale, NY 10530
135 Walgrove Ave, Dobbs Ferry, NY 10522
1000 Northern Blvd, Great Neck, NY 11021
Organization information
See more information about ROBERT RITCH at bizstanding.comGlaucoma Associates of Ny PC
New York, NY
Industry:
Ophtalmologist, Alternative Medicine, Ophthalmology, ...
Doing business as:
Ritch, Robert<br>Ritch, Robert MD<br>Glaucoma Associates of New York
Registration:
1983
Site:
Phone:
(212) 477-7540 (Phone)
Description:
Dr. Robert Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Surgeon Director and Chief of Glaucoma Services at the New York Eye & Ear Infirmary, New York City and...
Addresses:
310 E 14 St, New York, NY 10003
310 E 14, New York, NY 10003
310 E 14, New York, NY 10003
Managers:
Christopher C. Teng (Ophthalmology),Robert H. Ritch (Ophthalmology),Sung Chul Park (Ophthalmology),...
Features:
Emergency Service
Licensed:
Yes
Excluded services:
Non-ophthalmic surgery, oculoplastic surgery, retinal surgery
Open Hours:
Mon 7:00 AM-9:00 AM; Tue, Thu 7:00 AM-3:00 PM; Fri 7:00 AM-1:00 PM
New York Eye & Ear Infirmary - Robert Ritch MD
310 E 14 St #304, New York, NY 10003
Categories:
Ophthalmology Physicians & Surgeons, Physicians & Surgeons
Site:
Phone:
(212) 477-7540 (Phone)
Professional information
Dr. Robert Ritch, New York NY - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Glaucoma Associates of New York
121 E 60Th St, New York 10022
(212) 755-3838 (Phone)
New York Eye and Ear Infirmary
310 E 14Th St, New York 10003
(212) 979-4000 (Phone)
121 E 60Th St, New York 10022
(212) 755-3838 (Phone)
New York Eye and Ear Infirmary
310 E 14Th St, New York 10003
(212) 979-4000 (Phone)
Procedures:
Glaucoma, Glaucoma surgery, glaucoma treatment
Conditions:
Glaucoma
Certifications:
Ophthalmology
Awards:
Healthgrades Honor Roll
Languages:
English
Philosophy:
As a leading glaucoma specialist, i believe in doing everything possible to control a patient's glaucoma and never giving up. This includes not only lowering intraocular pressure, but also using anti-oxidants and other agents which may protect the optic nerve.
Education:
Medical School
Albert Einstein College Of Medicine Of Yeshiva University
Graduated: 1972
St Vincents Med Center
Graduated: 1973
Mt Sinai Med Center
Graduated: 1976
Graduated: 1978
Harvard College BA, Harvard University MA
Graduated: 1967
Albert Einstein College Of Medicine Of Yeshiva University
Graduated: 1972
St Vincents Med Center
Graduated: 1973
Mt Sinai Med Center
Graduated: 1976
Graduated: 1978
Harvard College BA, Harvard University MA
Graduated: 1967
Shelley And Steven Einhorn Distinguished Chair At New York Eye And Ear Infirmary
Position:
Shelley and Steven Einhorn Distinguished Chair at New York Eye and Ear Infirmary, President at Glaucoma Associates of New York
Location:
Greater New York City Area
Industry:
Medical Practice
Work:
New York Eye and Ear Infirmary
- New York, NY since 1983
-
Shelley and Steven Einhorn Distinguished Chair
Glaucoma Associates of New York
since 1983
-
President
Education:
Harvard University 1960 - 1967
BA, MA, Biology, Cell biology
BA, MA, Biology, Cell biology
Honor & Awards:
Ophthalmologist of the Year, Heed Foundation 1996
Gold Medal of Merit, Greek Glaucoma Society 1998
1998 Louis Rudin Award 1999
Honoree, Helen Keller Foundation 2000
Jesse H. Neal Award for Editorial Achievement 2000
Albion O. Bernstein, MD Award, NY Med Soc. 2006
AAO Lifetime Achievement Honor Award 2007
LEO award Am Acad Ophthalmol 2007
Dean’s Distinguished Research Award, New York Medical College 2007
Ronald F. Lowe Gold Medal Australia 2009
Dominick Purpura Award 2009
ARVO Distinguished Service Award 2010
HRH PrinceAbdulaziz Prevention of Blindness Award 2010
Jose Rizal International Medal 2011
Asia-Pacific Academy Achievement Award 2011
Revolution Award, Tunisia 2011
El-Maghraby International Award 2012
Elected to Academia Ophthalmologica Internationalis 2012
Ahti Tarkkanen Medal of the Nordic Opthalmologic Congress 2012
Inaugural Asia-Pacific Glaucoma Society International Award 2012
American Glaucoma Society Guest of Honor 2013
Sales Manager Fox Stations Sales
Location:
Greater New York City Area
Industry:
Marketing and Advertising
Robert Ritch, New York NY
Work:
Glaucoma Associates of New York
310 E 14Th St, New York, NY 10003 Glaucoma Associates of New York
121 East 60Th St, New York, NY 10022
310 E 14Th St, New York, NY 10003 Glaucoma Associates of New York
121 East 60Th St, New York, NY 10022
Method For The Treatment Of Glaucoma
US Patent:
5092837, Mar 3, 1992
Filed:
Aug 27, 1990
Appl. No.:
7/573323
Inventors:
Robert Ritch - New York NY
Edward E. Klein - Chappaqua NY
Edward E. Klein - Chappaqua NY
International Classification:
A61M 500
US Classification:
604 8
Abstract:
A method of permanently surgically treating glaucoma is disclosed together with an apparatus for effecting such treatment. In accordance with the method, an implant is disposed at a filtration site through the sclera the implant including a through going aperture leading from the anterior chamber to a bleb formed in the conjunctiva. The implant is retained in the sclera by radially compressing the same during the insertion procedure and thereafter releasing the radial compressive forces whereby the implant expands and is prevented from dislocation. An apparatus for effecting the implant is likewise disclosed, the apparatus including a cannula having a bore constraining the insert, a plunger for shifting the insert through an angularly offset opening in the cannula and a retainer filament engaged in the passage in the insert for controlling the precise location of the insert during the implant and for releasing the insert from connection to the cannula when the precise position is achieved.
Transscleral Drainage Implant Device For The Treatment Of Glaucoma
US Patent:
4968296, Nov 6, 1990
Filed:
Dec 20, 1989
Appl. No.:
7/454013
Inventors:
Robert Ritch - New York NY
Edward E. Klein - Chappaqua NY
Edward E. Klein - Chappaqua NY
International Classification:
A61M 500
US Classification:
604 8
Abstract:
A method of permanently surgically treating glaucoma is disclosed together with an apparatus for effecting such treatment. In accordance with the method, an implant is disposed at a filtration site through the sclera the implant including a through going aperture leading from the anterior chamber to a bleb formed in the conjunctiva. The implant is retained in the sclera by radially compressing the same during the insertion procedure and thereafter releasing the radial compressive forces whereby the implant expands and is prevented from dislocation. An apparatus for effecting the implant is likewise disclosed, the apparatus including a cannula having a bore constraining the insert, a plunger for shifting the insert through an angularly offset opening in the cannula and a retainer filament engaged in the passage in the insert for controlling the precise location of the insert during the implant and for releasing the insert from connection to the cannula when the precise position is achieved.
Methods And Formulations For Treating Glaucoma
US Patent:
2005016, Jul 28, 2005
Filed:
Jan 6, 2005
Appl. No.:
11/030588
Inventors:
Robert Ritch - New York NY, US
International Classification:
A61K035/78, A61K031/714, A61K031/525, A61K031/385
US Classification:
424752000, 514052000, 514440000, 514251000, 424728000, 424094100, 514565000, 514733000, 424746000
Abstract:
Embodiments of the invention are directed toward neuroprotective formulations that may prevent the progression of glaucoma by strengthening the resistance of nerve cells to damage. Some embodiments of the invention are directed toward neuroprotective formulations that may limit and prevent glaucomatous damage by blocking the mechanisms that lead to retinal ganglion cell death. Other embodiments of the invention involve specific component formulations and methods of using the formulations.